Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-25-004895
Filing Date
2025-01-21
Accepted
2025-01-21 16:15:50
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A tm2430478d2_s1a.htm S-1/A 533083
2 EXHIBIT 1.4 tm2430478d2_ex1-4.htm EX-1.4 43440
3 EXHIBIT 10.36 tm2430478d2_ex10-36.htm EX-10.36 198287
4 EXHIBIT 23.1 tm2430478d2_ex23-1.htm EX-23.1 2833
5 GRAPHIC tm2430478d2_s1img001.jpg GRAPHIC 3063
6 GRAPHIC tm2430478d2_s1img002.jpg GRAPHIC 29320
  Complete submission text file 0001104659-25-004895.txt   823919
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-283722 | Film No.: 25542662
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)